RT Journal Article
SR Electronic
T1 Limited specificity of SARS-CoV-2 antigen-detecting rapid diagnostic tests at low temperatures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.01.21250904
DO 10.1101/2021.02.01.21250904
A1 Verena Haage
A1 Andres Moreira-Soto
A1 Jilian A. Sacks
A1 Victor Corman
A1 Christian Drosten
A1 Felix Drexler
YR 2021
UL http://medrxiv.org/content/early/2021/02/03/2021.02.01.21250904.abstract
AB SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are available within and outside of health care settings to enable increased access to COVID-19 diagnosis. These environments include provisional testing facilities, lacking temperature control; as outside temperatures fall, recommended testing temperatures cannot be guaranteed. We report impaired specificity in two out of six Ag-RDTs when used at 2-4°C, indicating that testing in cold settings might cause false-positive results potentially entailing unwarranted quarantine assignments and incorrect incidence estimates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was partially supported by the Foundation for Innovative New Diagnostics (FIND), including procurement of some test kits. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of FIND.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The testing of employees is part of an ongoing study on SARS-CoV-2 infection in employees under Charite ethical review board file number EA1/068/20.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article.